— Know what they know.
Not Investment Advice

BZYR OTC

Burzynski Research Institute, Inc.
1W: +0.0% 1M: +25.0% 3M: -50.0% YTD: -90.0% 1Y: -94.9% 3Y: -97.1% 5Y: -93.1%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 42 · $262897 mcap · 25M float · 0.105% daily turnover · Short 33% of daily vol

Balance Sheet Trends

Total Assets
$847 -63.3% ▼
5Y CAGR: -46.8%
Total Liabilities
$42K +54.9% ▲
5Y CAGR: -24.4%
Shareholders Equity
-$42K -65.7% ▼
Cash & Investments
$847 -35.3% ▼
5Y CAGR: +39.0%
Total Debt
$0 +0.0% ▲
Net Debt
-$847 +35.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$62$3K$934$1K$847
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$62$3K$934$1K$847
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$956$5K$2K$2K$847
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$0$0$0
Total Assets$956$5K$2K$2K$847
— Liabilities —
Accounts Payable$33K$0$13K$9K$17K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$47K$3K$16K$27K$42K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$47K$3K$16K$27K$42K
— Equity —
Common Stock$131K$131K$131K$131K$131K
Retained Earnings-$125M-$126M-$127M-$128M-$129M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity-$46K$1K-$14K-$25K-$42K
Total Liabilities & Equity$956$5K$2K$2K$847
— Key Metrics —
Total Debt$0$0$0$0$0
Net Debt-$62-$3K-$934-$1K-$847
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms